Economic Evaluations of mHealth Interventions for the Management of Type 2 Diabetes: A Scoping Review
2023

Economic Evaluations of mHealth Interventions for Type 2 Diabetes

Sample size: 12 publication Evidence: moderate

Author Information

Author(s): Ida Tornvall, Danelle Kenny, Befikadu Legesse Wubishet, Anthony Russell, Anish Menon, Tracy Comans

Primary Institution: Centre for Health Services Research, The University of Queensland

Hypothesis

The review aims to summarize and critically analyze the current body of economic evaluation studies for mHealth interventions for type 2 diabetes.

Conclusion

mHealth interventions for type 2 diabetes can be cost-saving or cost-effective, but the quality of reporting in existing studies needs significant improvement.

Supporting Evidence

  • All studies reported their intervention to be cost-effective or cost-saving.
  • Most studies had a median CHEERS score of 59%, indicating moderate quality.
  • Interventions included text messages and smartphone applications, often with Bluetooth-connected medical devices.

Takeaway

This study looked at how mobile health tools can help people with diabetes save money and improve their health, but many studies didn't explain their findings well.

Methodology

A scoping review framework was used to summarize and critically analyze existing literature on economic evaluations of mHealth interventions for type 2 diabetes.

Potential Biases

Potential publication bias as all included studies reported positive outcomes.

Limitations

The review only included studies published in English and may have missed relevant studies published before 2007.

Participant Demographics

The studies included adults living with type 2 diabetes, with a majority from high-income countries.

Digital Object Identifier (DOI)

10.1177/19322968231183956

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication